Biotechnology in Asia-Pacific
- Pages: 39
- Published: December 2019
- Report Code: OHMF9191
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
– The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
– The Asia-Pacific biotechnology industry had total revenues of $99.5bn in 2018, representing a compound annual growth rate (CAGR) of 6.3% between 2014 and 2018.
– The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of $53.8bn, equivalent to 54.1% of the industry's overall value.
– The industry is driven mainly by Japan and China, which accounted for 37.6% and 20.9% of its total value in 2018.
Scope
– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
– Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
Reasons to buy
- What was the size of the Asia-Pacific biotechnology market by value in 2018?
- What will be the size of the Asia-Pacific biotechnology market in 2023?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
Companies mentioned
Shanghai Kehua Bio-engineering Co Ltd
Astellas Pharma China Inc
Novo Nordisk Pharmatech A/S
Takeda Pharmaceutical Company Limited
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.